Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
J Antimicrob Chemother. 2002 Aug;50(2):231-40. doi: 10.1093/jac/dkf101.
J Antimicrob Chemother. 2002.
PMID: 12161404
Clinical Trial.